Cargando…

E. coli Nissle 1917 ameliorates mitochondrial injury of granulosa cells in polycystic ovary syndrome through promoting gut immune factor IL-22 via gut microbiota and microbial metabolism

OBJECTIVE: Gut microbiota and its metabolites have regulatory effects on PCOS related ovarian dysfunction and insulin resistance. Escherichia coli Nissle 1917 (EcN) is a genetically controlled probiotic with an excellent human safety record for improving gut microbiome metabolic disorders and immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Man, Chen, Yuanyuan, Pan, Xiangyang, Chen, Hongmei, Fan, Lang, Wen, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235540/ https://www.ncbi.nlm.nih.gov/pubmed/37275915 http://dx.doi.org/10.3389/fimmu.2023.1137089

Ejemplares similares

Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
por: Ukena, Sya N., et al.
Publicado: (2007)

Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
por: Praveschotinunt, Pichet, et al.
Publicado: (2019)

Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance
por: Nzakizwanayo, Jonathan, et al.
Publicado: (2015)

Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota
por: Teng, Guigen, et al.
Publicado: (2022)

The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice
por: Rodríguez-Nogales, Alba, et al.
Publicado: (2018)

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
por: Tumas, Sarunas, et al.
Publicado: (2023)

Effects of Escherichia coli Nissle 1917 on the Porcine Gut Microbiota, Intestinal Epithelium and Immune System in Early Life
por: Geervliet, Mirelle, et al.
Publicado: (2022)

Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP‐1 and modulating gut microbiota
por: Wu, Heng, et al.
Publicado: (2022)

Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019)

Protocol for engineering E. coli Nissle 1917 to diagnose, record, and ameliorate inflammatory bowel disease in mice
por: Zou, Zhen-Ping, et al.
Publicado: (2023)

Tumor Colonization and Therapy by Escherichia coli Nissle 1917 Strain in Syngeneic Tumor-Bearing Mice Is Strongly Affected by the Gut Microbiome
por: Gentschev, Ivaylo, et al.
Publicado: (2022)

Gradient Magnetic Field Accelerates Division of E. coli Nissle 1917
por: Gorobets, Svitlana, et al.
Publicado: (2023)

Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
por: Pérez-Berezo, Teresa, et al.
Publicado: (2017)

Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917
por: Massip, Clémence, et al.
Publicado: (2019)

E. coli Nissle 1917 Affects Salmonella Adhesion to Porcine Intestinal Epithelial Cells
por: Schierack, Peter, et al.
Publicado: (2011)

The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
por: Bury, Susanne, et al.
Publicado: (2018)

Engineered E. coli Nissle 1917 for the reduction of vancomycin‐resistant Enterococcus in the intestinal tract
por: Geldart, Kathryn G., et al.
Publicado: (2018)

Effects of Escherichia coli strain Nissle 1917 on exercise-induced disruption of gastrointestinal integrity
por: Mooren, F. C., et al.
Publicado: (2020)

Transcriptional Profiling of the Probiotic Escherichia coli Nissle 1917 Strain under Simulated Microgravity
por: Yim, Jaewoo, et al.
Publicado: (2020)

No Genotoxicity Is Detectable for Escherichia coli Strain Nissle 1917 by Standard In Vitro and In Vivo Tests
por: Dubbert, Silke, et al.
Publicado: (2020)

Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model
por: Park, Jihye, et al.
Publicado: (2021)

Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917
por: Kan, Anton, et al.
Publicado: (2020)

Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa
por: Aljohani, Ahmad M., et al.
Publicado: (2023)

Impact of Escherichia coli probiotic strains ED1a and Nissle 1917 on the excretion and gut carriage of extended-spectrum beta-lactamase-producing E. coli in pigs
por: Mourand, Gwénaëlle, et al.
Publicado: (2021)

Effect of Probiotic E. coli Nissle 1917 Supplementation on the Growth Performance, Immune Responses, Intestinal Morphology, and Gut Microbes of Campylobacter jejuni Infected Chickens
por: Helmy, Yosra A., et al.
Publicado: (2022)

Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and diabetic mice
por: Shi, Jun, et al.
Publicado: (2023)

Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity
por: Olier, Maïwenn, et al.
Publicado: (2012)

Functional investigation of the chromosomal ccdAB and hipAB operon in Escherichia coli Nissle 1917
por: Xu, Jun, et al.
Publicado: (2020)

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917
por: Dusek, Otakar, et al.
Publicado: (2020)

A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917
por: Nougayrède, Jean-Philippe, et al.
Publicado: (2021)

E. coli Nissle 1917 modulates host glucose metabolism without directly acting on glucose
por: Chavkin, Theodore A., et al.
Publicado: (2021)

Engineered Escherichia coli Nissle 1917 with urate oxidase and an oxygen-recycling system for hyperuricemia treatment
por: Zhao, Rui, et al.
Publicado: (2022)

Efficient markerless integration of genes in the chromosome of probiotic E. coli Nissle 1917 by bacterial conjugation
por: Seco, Elena M., et al.
Publicado: (2021)

Antibacterial MccM as the Major Microcin in Escherichia coli Nissle 1917 against Pathogenic Enterobacteria
por: Ma, Yi, et al.
Publicado: (2023)

Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth
por: He, Lian, et al.
Publicado: (2017)

E. coli Nissle 1917-Derived Minicells for Targeted Delivery of Chemotherapeutic Drug to Hypoxic Regions for Cancer Therapy
por: Zhang, Yunlei, et al.
Publicado: (2018)

Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
por: Chen, Haojie, et al.
Publicado: (2023)

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers
por: Henker, Jobst, et al.
Publicado: (2007)

Insights from the molecular characterization of mercury stress proteins identified by proteomics in E.coli nissle 1917
por: Seshapani, Panthangi, et al.
Publicado: (2013)

Serial passage in an insect host indicates genetic stability of the human probiotic Escherichia coli Nissle 1917
por: Schröder, Nicolas C H, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2gldh96f30gppf2q9md6g948fj